These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1838105)

  • 1. Comparative therapeutic efficacy of teicoplanin and vancomycin in normal and in neutropenic mice infected with Staphylococcus haemolyticus.
    Torney HL; Balistreri FJ; Kenny MT; Cheng WD
    J Antimicrob Chemother; 1991 Aug; 28(2):261-9. PubMed ID: 1838105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative therapeutic efficacy of teicoplanin and vancomycin in normal and in neutropenic mice infected with Staphylococcus haemolyticus.
    Cunningham R
    J Antimicrob Chemother; 1992 Apr; 29(4):459-6. PubMed ID: 1535069
    [No Abstract]   [Full Text] [Related]  

  • 3. Effectiveness of teicoplanin versus vancomycin lock therapy in the treatment of port-related coagulase-negative staphylococci bacteraemia: a prospective case-series analysis.
    Del Pozo JL; García Cenoz M; Hernáez S; Martínez A; Serrera A; Aguinaga A; Alonso M; Leiva J
    Int J Antimicrob Agents; 2009 Nov; 34(5):482-5. PubMed ID: 19713086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of teicoplanin therapy in two neutropenic patients with staphylococcal septicemia who recovered after administration of vancomycin.
    Brunet F; Vedel G; Dreyfus F; Vaxelaire JF; Giraud T; Schremmer B; Monsallier JF
    Eur J Clin Microbiol Infect Dis; 1990 Feb; 9(2):145-7. PubMed ID: 2138543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of telavancin against glycopeptide-intermediate Staphylococcus aureus in the neutropenic mouse bacteraemia model.
    Hegde SS; Difuntorum S; Skinner R; Trumbull J; Krause KM
    J Antimicrob Chemother; 2009 Apr; 63(4):763-6. PubMed ID: 19155225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teicoplanin, vancomycin, rifampicin: in-vivo and in-vitro studies with Staphylococcus aureus.
    Carper HT; Sullivan GW; Mandell GL
    J Antimicrob Chemother; 1987 May; 19(5):659-62. PubMed ID: 2956229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enterococcus faecium sensitive to teicoplanin but not vancomycin.
    Wilson AP; Felmingham D; Robbins M; Chopra R
    J Hosp Infect; 1991 Aug; 18(4):322-4. PubMed ID: 1682372
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterisation of coagulase-negative staphylococci isolated from blood infections: incidence, susceptibility to glycopeptides, and molecular epidemiology.
    Boisson K; Thouverez M; Talon D; Bertrand X
    Eur J Clin Microbiol Infect Dis; 2002 Sep; 21(9):660-5. PubMed ID: 12373498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective case-control analysis of patients with staphylococcal infections receiving daptomycin or glycopeptide therapy.
    Falcone M; Russo A; Pompeo ME; Vena A; Marruncheddu L; Ciccaglioni A; Grossi P; Mancini C; Novelli A; Stefani S; Venditti M
    Int J Antimicrob Agents; 2012 Jan; 39(1):64-8. PubMed ID: 22047703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The use of teicoplanin in neutropenic patients: values and limits].
    Espinouse D; Chomarat M
    Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):552-6. PubMed ID: 2143573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gram-positive infections in neutropenic patients: glycopeptide antibiotic choice.
    Menichetti F
    J Antimicrob Chemother; 1992 Apr; 29(4):461-3. PubMed ID: 1535070
    [No Abstract]   [Full Text] [Related]  

  • 12. Bacteremia due to teicoplanin-resistant and vancomycin-susceptible Staphylococcus haemolyticus in seven patients with acute leukemia and neutropenia receiving prophylaxis with ofloxacin.
    Krcméry V; Trupl J; Spanik S
    Infection; 1997; 25(1):51-2. PubMed ID: 9039542
    [No Abstract]   [Full Text] [Related]  

  • 13. Teicoplanin in combination therapy for febrile episodes in neutropenic and non-neutropenic paediatric patients.
    Lemerle S; de La Rocque F; Lamy R; Fremaux A; Bernaudin F; Lobut JB; Reinert P
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():113-6. PubMed ID: 2965122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of treatment with teicoplanin at 6 milligrams/kilogram/day in patients with Staphylococcus aureus intravascular infection. The Infectious Diseases Consortium of Oregon.
    Gilbert DN; Wood CA; Kimbrough RC
    Antimicrob Agents Chemother; 1991 Jan; 35(1):79-87. PubMed ID: 1826594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of glycopeptides against Staphylococcus aureus infection in a rabbit endocarditis model: MICs do not predict in vivo efficacy.
    Asseray N; Jacqueline C; Le Mabecque V; Batard E; Bugnon D; Potel G; Caillon J
    Antimicrob Agents Chemother; 2005 Feb; 49(2):857-9. PubMed ID: 15673789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of teicoplanin or vancomycin for the treatment of documented bacteremia due to gram-positive cocci in neutropenic patients with hematological malignancies: microbiological, clinical and economic evaluation.
    D'Antonio D; Staniscia T; Piccolomini R; Fioritoni G; Rotolo S; Parruti G; Di Bonaventura G; Manna A; Savini V; Fiorilli MP; Di Giovanni P; Francione A; Schioppa F; Romano F
    Chemotherapy; 2004 Jun; 50(2):81-7. PubMed ID: 15211082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of glycopeptide antibiotics in the treatment of febrile neutropenic patients.
    Smith SR; Cheesbrough J; Harding I; Davies JM
    Br J Haematol; 1990 Dec; 76 Suppl 2():54-6. PubMed ID: 2149054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controversies on antibiotic lock technique duration: experience with a 3-day course for hematological patients.
    Tendas A; Niscola P; Cupelli L; Spagnoli A; Scaramucci L; Giovannini M; Ales M; Cudillo L; Picardi A; Mirabile M; Bove F; Falco S; Dentamaro T; Fabritiis Pd
    Infect Control Hosp Epidemiol; 2011 Apr; 32(4):408-10. PubMed ID: 21460500
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of efficacy and safety of teicoplanin and vancomycin in children with antineoplastic therapy-associated febrile neutropenia and gram-positive bacteremia.
    Sidi V; Roilides E; Bibashi E; Gompakis N; Tsakiri A; Koliouskas D
    J Chemother; 2000 Aug; 12(4):326-31. PubMed ID: 10949982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Characteristics of Methicillin-resistant Coagulase-negative Staphylococcal Bacteremia in a Tertiary Hospital.
    Yamada K; Namikawa H; Fujimoto H; Nakaie K; Takizawa E; Okada Y; Fujita A; Kawaguchi H; Nakamura Y; Abe J; Kaneko Y; Kakeya H
    Intern Med; 2017; 56(7):781-785. PubMed ID: 28381743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.